Sun et al., 2021 - Google Patents
Comparative study of two contrast agents for intraoperative identification of sentinel lymph nodes in patients with early breast cancerSun et al., 2021
View HTML- Document ID
- 3280377624684951482
- Author
- Sun Y
- Cui L
- Wang S
- Shi T
- Hao Y
- Lei Y
- Publication year
- Publication venue
- Gland Surgery
External Links
Snippet
Background The use of contrast-enhanced ultrasound (CEUS) to locate sentinel lymph nodes (SLNs) in breast cancer has been studied more and more in recent years. This prospective study aimed to compare periareolar injection of two different contrast agents …
- 210000001165 Lymph Nodes 0 title abstract description 51
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/418—Evaluating particular organs or parts of the immune or lymphatic systems lymph vessels, ducts or nodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/48—Diagnostic techniques
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sarkar et al. | A review of imaging methods for prostate cancer detection: supplementary issue: image and video acquisition and processing for clinical applications | |
| Langer et al. | Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2—sparse versus dense cancers | |
| Hlawatsch et al. | Preoperative assessment of breast cancer: sonography versus MR imaging | |
| Bazzocchi et al. | Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of a multicenter trial | |
| Yeh et al. | Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer | |
| Pucar et al. | Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy–initial experience | |
| Wei et al. | Contrast-enhanced ultrasound for differentiating benign from malignant solid small renal masses: comparison with contrast-enhanced CT | |
| Xiang et al. | Contrast-enhanced ultrasound (CEUS) facilitated US in detecting lateral neck lymph node metastasis of thyroid cancer patients: diagnosis value and enhancement patterns of malignant lymph nodes | |
| Rubini et al. | Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125 | |
| Dong et al. | Application of imaging fusion combining contrast‐enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound | |
| Vidili et al. | SIUMB guidelines and recommendations for the correct use of ultrasound in the management of patients with focal liver disease | |
| Ghai et al. | Comparison of micro-US and multiparametric MRI for prostate cancer detection in biopsy-naive men | |
| Jiang et al. | Intratumoral and peritumoral analysis of mammography, tomosynthesis, and multiparametric MRI for predicting Ki-67 level in breast cancer: a radiomics-based study | |
| Wang et al. | Shear wave elastography-based ultrasomics: differentiating malignant from benign focal liver lesions | |
| Li et al. | MR elastography-based shear strain mapping for assessment of microvascular invasion in hepatocellular carcinoma | |
| Gheonea et al. | Beyond conventional endoscopic ultrasound: elastography, contrast enhancement and hybrid techniques | |
| Huang et al. | The benefit of contrast-enhanced ultrasound in biopsies for focal liver lesions: a retrospective study of 820 cases | |
| Sun et al. | Comparative study of two contrast agents for intraoperative identification of sentinel lymph nodes in patients with early breast cancer | |
| Xian et al. | Prediction of lymph node metastasis in rectal cancer: comparison between shear-wave elastography based ultrasomics and MRI | |
| Guo et al. | Contrast-enhanced ultrasound–based nomogram for predicting malignant involvements among sonographically indeterminate/suspicious cervical lymph nodes in patients with differentiated thyroid carcinoma | |
| Ding et al. | Value of contrast-enhanced ultrasound in predicting early lymph-node metastasis in oral cancer | |
| Ma et al. | Success of image-guided biopsy for small (≤ 3 cm) focal liver lesions in cirrhotic and noncirrhotic individuals | |
| Zhang et al. | Real-Time Elastography in the diagnosis of prostate cancer: a systematic review | |
| Shi et al. | Accuracy of conventional ultrasound, contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging in assessing the size of breast cancer | |
| Zhu et al. | A preoperative nomogram for predicting the risk of sentinel lymph node metastasis in patients with T1-2N0 breast cancer |